Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya.As of 26 May 2026, MEDICAMEN ORGANICS LTD share price is ₹24.20. The stock opened at ₹24.45, compared to its previous close of ₹24.45. During today's trading session, MEDICAMEN ORGANICS LTD share price moved in the range of ₹24.00 to ₹24.90, with an average price of ₹24.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.00 and a high of ₹24.90. On the performance front, MEDICAMEN ORGANICS LTD share price has declined by 11.84% over the last six months and is down 20.39% on a year-on-year basis.
The market capitalization of MEDICAMEN ORGANICS LTD is ₹25 Crs, with a P/E ratio of 6.3 and a dividend yield of 0.00%.